Summit stock soars as lung cancer drug beats Merck’s Keytruda in late-stage trial Source: Seekingalpha
Browsing: latestage
Summit stock soars as lung cancer drug beats Merck’s Keytruda in late-stage trial Source: Seekingalpha
Summit stock soars as lung cancer drug beats Merck’s Keytruda in late-stage trial Source: Seekingalpha
GSK’s Nucala succeeds in late-stage study for lung dysfunction, COPD Source: Seekingalpha
GSK’s Nucala succeeds in late-stage study for lung dysfunction, COPD Source: Seekingalpha
GSK’s Nucala succeeds in late-stage study for lung dysfunction, COPD Source: Seekingalpha
Eli Lilly marks late-stage trial win for once weekly insulin Source: Seekingalpha